Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

£625m 'wasted on synthetic insulin'

  • Comment

The NHS has wasted £625 million on synthetic insulin over the past decade, according to a report published today.

The researchers based the figure on savings that could have been made by using human alternatives.

The study, published online in BMJ Open, found that in the last 10 years the NHS spent a total of £2.732 billion on insulin.

The annual cost of synthetic insulin rose from £18.2 million to £305 million while the cost of human insulin fell from £131 million to £51 million.

The Cardiff University report found that - based on the assumption that all patients could have been prescribed human insulin - the NHS could have saved itself £625 million.

Its authors concluded: “We know that the rise of insulin analogues has had a substantial financial impact on the NHS, yet over the same period there has been no observable clinical benefit to justify that investment.

“It is likely that there was, and is, considerable scope for financial savings.”

 

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.